It seems reasonable to me to now conclude that the approval of...

It seems reasonable to me to now conclude that the approval of dossiers is not having the intended impact on the sp that I assumed that they would

Since the sp is as low now as pre the approvals, one can only assume that the market has already anticipated that the approvals are on track and the current valuation includes the value of the approved dossiers. Weird, but there you have it.

By extension the sp will not likely move if any further approvals are achieved - only fall if the approvals do not materialise.

So one might ask what will cause the sp to rise? Perhaps the only thing the market will value is a positive response when the drugs hit the market and presumably as the dollars roll in. I suspect we are in for another long wait.

Shite!